Proteome-metabolome profiling of ovarian cancer ascites reveals novel components involved in intercellular communication

Molecular and Cellular Proteomics

Volumn 13, Issue 12, 2014, Pages 3558-3571

  Shender, Victoria O ^a,h   Pavlyukov, Marat S ^a,h   Ziganshin, Rustam H ^a   Arapidi, Georgij P ^a,b   Kovalchuk, Sergey I ^a   Anikanov, Nikolay A ^a   Altukhov, Ilya A ^b,c   Alexeev, Dmitry G ^b,c   Butenko, Ivan O ^c   Shavarda, Alexey L ^d,e   Khomyakova, Elena B ^c   Evtushenko, Evgeniy ^f   Ashrafyan, Lev A ^g   Antonova, Irina B ^g   Kuznetcov, Igor N ^g   Gorbachev, Alexey Yu ^c   Shakhparonov, Mikhail I ^a   Govorun, Vadim M ^a,c,h  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b MOSCOW INSTITUTE OF PHYSICS AND TECHNOLOGY   (Russian Federation)

^c FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY   (Russian Federation)

^d ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

^e KOMAROV BOTANICAL INSTITUTE   (Russian Federation)

^f MOSCOW STATE UNIVERSITY   (Russian Federation)

^g Ministry of Health of the Russian Federation   (Russian Federation)

^h KAZAN FEDERAL UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEOME; RNA; TUMOR PROTEIN;

ARTICLE; CANCER CELL; CELL COMMUNICATION; CONTROLLED STUDY; EXOSOME; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CIRRHOSIS; MALIGNANT ASCITES; METABOLOME; OVARIAN CANCER CELL LINE; OVARY CANCER; PRIORITY JOURNAL; RNA SPLICING; SIGNAL TRANSDUCTION; ALTERNATIVE RNA SPLICING; ASCITES; CHEMISTRY; FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OVARY TUMOR; PATHOLOGY; SPLICEOSOME; TRANSPORT VESICLE; TUMOR CELL LINE;

ALTERNATIVE SPLICING; ASCITES; CELL COMMUNICATION; CELL LINE, TUMOR; EXOSOMES; FEMALE; FIBROSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; METABOLOME; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PROTEOME; RNA, NEOPLASM; SIGNAL TRANSDUCTION; SPLICEOSOMES; TRANSPORT VESICLES;

EID: 84928243525     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M114.041194     Document Type: Article

References (45)

1. Kozak, K. R., Su, F., Whitelegge, J. P., Faull, K., Reddy, S., and Farias-Eisner, R. (2005) Characterization of serum biomarkers for detection of early stage ovarian cancer. Proteomics 5, 4589-4596
2. Kipps, E., Tan, D. S., and Kaye, S. B. (2013) Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research. Nat. Rev. Cancer 13, 273-282
3. Gortzak-Uzan, L., Ignatchenko, A., Evangelou, A. I., Agochiya, M., Brown, K. A., St Onge, P., Kireeva, I., Schmitt-Ulms, G., Brown, T. J., Murphy, J., Rosen, B., Shaw, P., Jurisica, I., and Kislinger, T. (2008) A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers. J. Proteome Res. 7, 339-351
4. Dunn, W. B., Broadhurst, D., Begley, P., Zelena, E., Francis-McIntyre, S., Anderson, N., Brown, M., Knowles, J. D., Halsall, A., Haselden, J. N., Nicholls, A. W., Wilson, I. D., Kell, D. B., and Goodacre, R. (2011) Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat. Protoc. 6, 1060-1083
5. Karimi, P., Shahrokni, A., and Nezami Ranjbar, M. R. (2014) Implementation of proteomics for cancer research: past, present, and future. Asian Pacific J. Cancer Prev. 15, 2433-2438
6. O'Connell, T. M. (2012) Recent advances in metabolomics in oncology. Bioanalysis 4, 431-451
7. Vermeersch, K. A., and Styczynski, M. P. (2013) Applications of metabolomics in cancer research. J. Carcinogenesis 12, 9
8. Drabovich, A. P., and Diamandis, E. P. (2010) Combinatorial peptide libraries facilitate development of multiple reaction monitoring assays for low-abundance proteins. J. Proteome Res. 9, 1236-1245
9. Kuk, C., Kulasingam, V., Gunawardana, C. G., Smith, C. R., Batruch, I., and Diamandis, E. P. (2009) Mining the ovarian cancer ascites proteome for potential ovarian cancer biomarkers. Mol. Cell. Proteomics 8, 661-669
10. Elschenbroich, S., Ignatchenko, V., Clarke, B., Kalloger, S. E., Boutros, P. C., Gramolini, A. O., Shaw, P., Jurisica, I., and Kislinger, T. (2011) In-depth proteomics of ovarian cancer ascites: combining shotgun proteomics and selected reaction monitoring mass spectrometry. J. Proteome Res. 10, 2286-2299
11. Zhou, M., Guan, W., Walker, L. D., Mezencev, R., Benigno, B. B., Gray, A., Fernandez, F. M., and McDonald, J. F. (2010) Rapid mass spectrometric metabolic profiling of blood sera detects ovarian cancer with high accuracy. Cancer Epidemiol. Biomarkers Prev. 19, 2262-2271
12. Odunsi, K., Wollman, R. M., Ambrosone, C. B., Hutson, A., McCann, S. E., Tammela, J., Geisler, J. P., Miller, G., Sellers, T., Cliby, W., Qian, F., Keitz, B., Intengan, M., Lele, S., and Alderfer, J. L. (2005) Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics. Int. J. Cancer 113, 782-788
13. Zhang, T., Wu, X., Ke, C., Yin, M., Li, Z., Fan, L., Zhang, W., Zhang, H., Zhao, F., Zhou, X., Lou, G., and Li, K. (2013) Identification of potential biomarkers for ovarian cancer by urinary metabolomic profiling. J. Proteome Res. 12, 505-512
14. Ghasemi, N., Ghobadzadeh, S., Zahraei, M., Mohammadpour, H., Bahrami, S., Ganje, M. B., and Rajabi, S. (2014) HE4 combined with CA125: favorable screening tool for ovarian cancer. Med. Oncol. 31, 808
15. Anderson, N. L., Polanski, M., Pieper, R., Gatlin, T., Tirumalai, R. S., Conrads, T. P., Veenstra, T. D., Adkins, J. N., Pounds, J. G., Fagan, R., and Lobley, A. (2004) The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol. Cell. Proteomics 3, 311-326
16. Boschetti, E., Lomas, L., Citterio, A., and Righetti, P. G. (2007) Romancing the "hidden proteome." J. Chromatogr. A 1153, 277-290
17. Kumar, S., Donti, T. R., Agnihotri, N., and Mehta, K. (2013) Transglutaminase 2 reprogramming of glucose metabolism in mammary epithelial cells via activation of inflammatory signaling pathways. Int. J. Cancer 134, 2798-2807
18. McCready, J., Sims, J. D., Chan, D., and Jay, D. G. (2010) Secretion of extracellular hsp90alpha via exosomes increases cancer cell motility: a role for plasminogen activation. BMC Cancer 10, 294
19. Valadkhan, S., and Jaladat, Y. (2010) The spliceosomal proteome: at the heart of the largest cellular ribonucleoprotein machine. Proteomics 10, 4128-4141
20. Chen, M., and Manley, J. L. (2009) Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat. Rev. Mol. Cell Biol. 10, 741-754
21. Maciejewski, J. P., and Padgett, R. A. (2012) Defects in spliceosomal machinery: a new pathway of leukaemogenesis. Br. J. Haematol. 158,165-173
22. Zhou, Z., and Fu, X. D. (2013) Regulation of splicing by SR proteins and SR protein-specific kinases. Chromosoma 122, 191-207
23. Laetsch, T. W., Liu, X., Vu, A., Sliozberg, M., Vido, M., Elci, O. U., Goldsmith, K. C., and Hogarty, M. D. (2014) Multiple components of the spliceosome regulate Mcl1 activity in neuroblastoma. Cell Death Dis. 5, e1072
24. Bonnal, S., Vigevani, L., and Valcarcel, J. (2012) The spliceosome as a target of novel antitumour drugs. Nat. Rev. Drug Discov. 11, 847-859
25. Hoy, A. M., and Buck, A. H. (2012) Extracellular small RNAs: what, where, why? Biochem. Soc. Trans. 40, 886-890
26. Taylor, D. D., and Gercel-Taylor, C. (2008) MicroRNA signatures of tumorderived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol. 110, 13-21
27. Wang, K., Zhang, S., Weber, J., Baxter, D., and Galas, D. J. (2010) Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res. 38, 7248-7259
28. Will, C. L., Schneider, C., Hossbach, M., Urlaub, H., Rauhut, R., Elbashir, S., Tuschl, T., and Luhrmann, R. (2004) The human 18S U11/U12 snRNP contains a set of novel proteins not found in the U2-dependent spliceosome. RNA 10, 929-941
29. Jang, M., Kim, S. S., and Lee, J. (2013) Cancer cell metabolism: implications for therapeutic targets. Exp. Mol. Med. 45, e45
30. Currie, E., Schulze, A., Zechner, R., Walther, T. C., and Farese, R. V., Jr. (2013) Cellular fatty acid metabolism and cancer. Cell Metab. 18, 153-161
31. Santos, C. R., and Schulze, A. (2012) Lipid metabolism in cancer. FEBS J. 279, 2610-2623
32. Hartmann, D., Lucks, J., Fuchs, S., Schiffmann, S., Schreiber, Y., Ferreiros, N., Merkens, J., Marschalek, R., Geisslinger, G., and Grosch, S. (2012) Long chain ceramides and very long chain ceramides have opposite effects on human breast and colon cancer cell growth. Int. J. Biochem. Cell Biol. 44, 620-628
33. Mills, G. B., and Moolenaar, W. H. (2003) The emerging role of lysophosphatidic acid in cancer. Nat. Rev. Cancer 3, 582-591
34. Kuwata, S., Ohkubo, K., Kumamoto, S., Yamaguchi, N., Izuka, N., Murota, K., Tsujiuchi, T., Iwamori, M., and Fukushima, N. (2013) Extracellular lipid metabolism influences the survival of ovarian cancer cells. Biochem. Biophys. Res. Commun. 439, 280-284
35. Oda, S. K., Strauch, P., Fujiwara, Y., Al-Shami, A., Oravecz, T., Tigyi, G., Pelanda, R., and Torres, R. M. (2013) Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression. Cancer Immunol. Res. 1, 245-255
36. Bian, S., Zhang, L., Duan, L., Wang, X., Min, Y., and Yu, H. (2013) Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model. J. Mol. Med. 92, 387-397
37. Leary, A., Auclin, E., Pautier, P., and Lhommé, C. (2013) Ovarian Cancer-A Clinical and Translational Update, InTech, Rijeka, Croatia
38. Quidville, V., Alsafadi, S., Goubar, A., Commo, F., Scott, V., Pioche-Durieu, C., Girault, I., Baconnais, S., Le Cam, E., Lazar, V., Delaloge, S., Saghatchian, M., Pautier, P., Morice, P., Dessen, P., Vagner, S., and Andre, F. (2013) Targeting the deregulated spliceosome core machinery in cancer cells triggers mTOR blockade and autophagy. Cancer Res. 73, 2247-2258
39. Weber, J. A., Baxter, D. H., Zhang, S., Huang, D. Y., Huang, K. H., Lee, M. J., Galas, D. J., and Wang, K. (2010) The microRNA spectrum in 12 body fluids. Clin. Chem. 56, 1733-1741
40. Arroyo, J. D., Chevillet, J. R., Kroh, E. M., Ruf, I. K., Pritchard, C. C., Gibson, D. F., Mitchell, P. S., Bennett, C. F., Pogosova-Agadjanyan, E. L., Stirewalt, D. L., Tait, J. F., and Tewari, M. (2011) Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl. Acad. Sci. U.S.A. 108, 5003-5008
41. Turchinovich, A., Weiz, L., Langheinz, A., and Burwinkel, B. (2011) Characterization of extracellular circulating microRNA. Nucleic Acids Res. 39, 7223-7233
42. Vickers, K. C., Palmisano, B. T., Shoucri, B. M., Shamburek, R. D., and Remaley, A. T. (2011) MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 13, 423-433
43. Ladd, J. J., Chao, T., Johnson, M. M., Qiu, J., Chin, A., Israel, R., Pitteri, S. J., Mao, J., Wu, M., Amon, L. M., McIntosh, M., Li, C., Prentice, R., Disis, N., and Hanash, S. (2013) Autoantibody signatures involving glycolysis and splicesome proteins precede a diagnosis of breast cancer among postmenopausal women. Cancer Res. 73, 1502-1513
44. Théry, C., Amigorena, S., Raposo, G., and Clayton, A. (2006) Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol. Chapter 3:Unit 3 22
45. ASTM E2834-12, Standard Guide for Measurement of Particle Size Distribution of Nanomaterials in Suspension by Nanoparticle Tracking Analysis (NTA), ASTM International, West Conshohocken, PA, 2012, www. astm.org.